Acute promyelocytic leukemia in pregnancy: Balancing treatment and toxicity
Clinical Hematology International: Case Reports · 08.10.2026 · 1 (4)
DOI: 10.46989/001c.171959 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hematology International: Case Reports, online erschienen am 08.10.2026. Verfasst von Catalina Bosch und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute promyelocytic leukemia (APL) during pregnancy is an exceptionally rare event, estimated at fewer than 1 per 100,000 pregnancies, reflecting the convergence of a hematologic emergency and the therapeutic challenges of gestation [1]. We report a 37-year-old woman at 22 weeks of gestation, referred for lower-limb edema and extensive bruising. Laboratory workup showed severe pancytopenia with early coagulopathy. Bone marrow examination confirmed APL by flow cytometry, cytogenetics, and molecular studies, which demonstrated the t(15;17) translocation and the PML-RARA fusion transcript [2]. Multidisciplinary assessment led to treatment with all-trans retinoic acid (ATRA); arsenic trioxide (ATO) was withheld for its teratogenic potential [2–4]. The course was complicated by differentiation syndrome, disseminated intravascular coagulation, and progressive obstetric deterioration, requiring corticosteroids, ICU admission, and dynamic adjustments [2,3,5,6]. Cesarean delivery occurred at 30 weeks of gestation with intensive transfusion support. The patient is now on ATRA/ATO consolidation with favorable evolution; the newborn, after prematurity-related complications, has been discharged from the neonatal ICU. This case, together with a focused review of the available literature, illustrates the complexity of managing APL during pregnancy and highlights continuous inpatient care, multidisciplinary collaboration, and real-time decision-making as central to its management [1-3].
Zitieren
APA
Bosch, C., Pérez=Lloveras, E., Blanco-Ziegler, M. D. L. M., Brulc, E., & Aguirre, M. (2026). Acute promyelocytic leukemia in pregnancy: Balancing treatment and toxicity. Clinical Hematology International: Case Reports, 1(4). https://doi.org/10.46989/001c.171959
Vancouver
Bosch C, Pérez=Lloveras E, Blanco-Ziegler MDLM, Brulc E, Aguirre M. Acute promyelocytic leukemia in pregnancy: Balancing treatment and toxicity. Clinical Hematology International: Case Reports. 2026;1(4). doi:10.46989/001c.171959
BibTeX
@article{Bosch2026,
author = {Bosch, Catalina and Pérez=Lloveras, Eugenia and Blanco-Ziegler, María de los Milagros and Brulc, Erika-Barbara and Aguirre, María-Adela},
title = {Acute promyelocytic leukemia in pregnancy: Balancing treatment and toxicity},
journal = {Clinical Hematology International: Case Reports},
year = {2026},
volume = {1},
number = {4},
doi = {10.46989/001c.171959}
}
EUVIMED